Erdafitinib in Asian Patients with Advanced Solid Tumors: an Open-Label, Single-Arm, Phase IIa Trial
BMC CANCER(2024)
Key words
Cholangiocarcinoma,NSCLC,Erdafitinib,FGFR inhibitor,Asian patients
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined